Using data from company's past performance alongside ownership research, one can better assess the future performance of a company This technology could replace computers: discover the 20 stocks are ...
TipRanks on MSN
PureTech Health appoints Robert Lyne as CEO
PureTech Health (PRTC) announces that the board of directors has appointed Robert Lyne as CEO, and as a member of the board of directors, ...
BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with ...
PureTech Systems Inc., a provider of geospatial AI-boosted video analytics for wide-area perimeter and border security, is proud to announce the integration of its patented PureActiv software with ...
Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks An announcement from PureTech Health ...
BOSTON, July 08, 2025--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of ...
PureTech Health has pieced together a wholly owned pipeline in recent years, picking up a prospect from Teva while taking ownership of Ariya Therapeutics and Alivio Therapeutics. With the expansion ...
BOSTON--(BUSINESS WIRE)--PureTech Health plc (LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly ...
PureTech Systems Inc. today announced the release of its new Interface Control Document (ICD). This essential document provides detailed information on the interfacing requirements necessary for ...
Biotech startup engine PureTech pulled off a $171 million IPO on the London Stock Exchange, crossing the Atlantic to raise cash for its hybrid approach to venture investing. The company priced about ...
PureTech Health is stepping up its bid to challenge Sage Therapeutics for the depression market by moving a rival to Zulresso and zuranolone into the clinic. The study in healthy volunteers marks the ...
PureTech Health has launched a subsidiary company – Celea Therapeutics – with the task of taking an experimental drug for idiopathic pulmonary fibrosis into late-stage clinical testing. Celea has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback